daunorubicin has been researched along with Cancer of Pharynx in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blayney, DW; Flanagan, B; Kennedy, P; Lisak, J; Presant, CA; Presant, J; Scolaro, M | 1 |
| Leibundgut, K; Plüss, HJ; Willi, U | 1 |
| Exelby, P; Filippa, D; Lieberman, P; Mandell, L; McGowan, N; Wollner, N | 1 |
1 trial(s) available for daunorubicin and Cancer of Pharynx
| Article | Year |
|---|---|
Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Daunorubicin; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Pharyngeal Neoplasms; Quality of Life; Remission Induction; Sarcoma, Kaposi; Treatment Outcome | 1993 |
2 other study(ies) available for daunorubicin and Cancer of Pharynx
| Article | Year |
|---|---|
Thymic rebound following successful chemotherapy of B-lymphoma in an adolescent boy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Lymphoma, B-Cell; Male; Pharyngeal Neoplasms; Prednisone; Thymus Hyperplasia; Tomography, X-Ray Computed; Vincristine | 1992 |
Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Neoplasm Staging; Nose Neoplasms; Oropharyngeal Neoplasms; Paranasal Sinus Neoplasms; Pharyngeal Neoplasms; Prednisone; Vincristine | 1990 |